NCT06617182View on ClinicalTrials.gov

Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2026

Conditions

Radiation Enteritis

Interventions

DRUG

Thalidomide

Patients in thalidomide group took thalidomide orally at a dose of 100mg once a day for 8 weeks.

DRUG

Glutamine

In the glutamine group, two capsules of glutamine were taken orally 3 times a day for 8 weeks.

DRUG

Thalidomide+Glutamine

Patients in thalidomide combined with glutamine group took thalidomide orally at a dose of 100mg once a day and two capsules of glutamine were taken orally 3 times a day for 8 weeks.

All Listed Sponsors

lead

Yongquan Shi

OTHER

NCT06617182 - Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury. | Biotech Hunter | Biotech Hunter